PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1109
https://www.valueinhealthjournal.com/article/S1098-3015(12)02822-7/fulltext
Section Title :
Infection
Section Order :
610
First Page :
A392
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02822-7&doi=10.1016/j.jval.2012.08.1109